Showing results (621-630 of 1,303) with videos related to
Sort By:
Pageof 131
Journal of Gynecologic Oncology|May 15, 2026
Toward harmonized gynecologic oncology education in Asia: a meeting report from the first ASYGO session at ASGO 2025Miseon Nakazawa, Takuya Kuboya, Xinyue Zhang, et al.Journal of Gynecologic Oncology|May 22, 2026
Chemotherapy plus camrelizumab for fertility preservation (NACI-F) in FIGO stage IB1 cervical cancer: a multicenter, single-arm, phase 2 trialYingjie Hu, Shuting Chen, Hanxu Cheng, et al.Journal of Gynecologic Oncology|February 1, 2024
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancerKan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, et al.Journal of Gynecologic Oncology|June 7, 2026
Agreement between INDICAID™ HPV (human papillomavirus) Urine Test and BD Onclarity™ HPV Assay in detection of high-risk HPV in self-collected urine samplesKar Kei Yung, Long Nguyen-Hoang, Wing May Nikki Lee, et al.Journal of Gynecologic Oncology|June 12, 2026
Prognostic outcomes in patients of low-grade endometrioid carcinoma confined to the adnexa who received no adjuvant therapy: a retrospective analysisXiaoyan Zhao, Shuilian Yao, Nankun Leng, et al.Journal of Gynecologic Oncology|January 23, 2015
Asian Society of Gynecologic Oncology International Workshop 2014Jeong Yeol Park, Hextan Yuen Sheung Ngan, Won Park, et al.Journal of Gynecologic Oncology|July 7, 2026
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG networkThomas Gaillard, Judicael Hotton, Enora Laas, et al.Journal of Gynecologic Oncology|July 7, 2026
Evaluator-blinded, randomized, multi-center study to evaluate the efficacy and safety of Medicurtain® in patients undergoing laparoscopic hysterectomyYeongTak Kim, JiYeong Choi, TaeJin Kim, et al.Journal of Gynecologic Oncology|June 27, 2026
p16(INK4a) immunohistochemical expression is a strong predictor of treatment response and survival in patients with locally advanced squamous cell vulvar cancer undergoing upfront chemoradiotherapyAlex Federico, Simona Maria Fragomeni, Valentina Lancellotta, et al.Journal of Gynecologic Oncology|July 31, 2026
The prognostic value of surgery in patients with locally advanced vulvar cancer: results from the SEER database and a Chinese multicenter registryJiaqi Xu, Penglin Liu, Haifeng Qiu, et al.Pageof 131